|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 28, 2022 11:11AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 27, 2022 06:45PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 27, 2022 06:39PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 26, 2022 01:27PM
|
|
HDL and apabetalone
|
11
|
Resverlogix Corp.
|
Apr 23, 2022 11:42AM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
12
|
Resverlogix Corp.
|
Apr 20, 2022 11:51AM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 19, 2022 12:08PM
|
|
Club or Business
|
9
|
Resverlogix Corp.
|
Apr 17, 2022 11:59AM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
3
|
Zenith Epigenetics
|
Apr 14, 2022 01:12PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 13, 2022 12:16PM
|
|
Re: Seems to be some interest
|
5
|
Resverlogix Corp.
|
Apr 12, 2022 06:04PM
|
|
Re: Seems to be some interest
|
8
|
Resverlogix Corp.
|
Apr 12, 2022 08:58AM
|
|
Re: Covid China
|
5
|
Resverlogix Corp.
|
Mar 30, 2022 05:50PM
|
|
Re: Thumbs up for Chris!
|
6
|
Resverlogix Corp.
|
Mar 29, 2022 05:39PM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 05:27PM
|
|
Re: Was checking out SEDAR...
|
5
|
Zenith Epigenetics
|
Mar 29, 2022 11:25AM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 11:11AM
|
|
Re: Covid China
|
3
|
Resverlogix Corp.
|
Mar 29, 2022 10:06AM
|
|
Covid China
|
5
|
Resverlogix Corp.
|
Mar 28, 2022 05:33PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
4
|
Resverlogix Corp.
|
Mar 26, 2022 07:24AM
|
